Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Don't Overlook These Top Fintech Stocks After Interest Rate Cuts | zacks.com • |
Paypal (PYPL) Ascends While Market Falls: Some Facts to Note | zacks.com • |
Paypal (PYPL) Ascends While Market Falls: Some Facts to Note | news.google.com • |
PayPal Is About To Pay Off | seekingalpha.com • |
PayPal Is About To Pay Off (NASDAQ:PYPL) | news.google.com • |
Amazon Teams With PayPal as Buy With Prime Shoppers Jump 50% | pymnts.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-06 | 2024-09 | 1.06 | N/A | N/A | N/A |
2024-07-30 | 2024-06 | 0.96 | 1.19 | 0.23 | 23.96% |
2024-04-30 | 2024-03 | 1.2 | 1.4 | 0.2 | 16.67% |
2024-02-07 | 2023-12 | 1.36 | 1.48 | 0.12 | 8.82% |
2023-11-01 | 2023-09 | 1.22 | 1.3 | 0.08 | 6.56% |
2023-08-02 | 2023-06 | 1.16 | 1.16 | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-17 | Oppenheimer | Upgrade | Outperform | Outperform |
2023-10-16 | Truist Securities | Upgrade | Buy | Buy |
2023-10-12 | HSBC | Upgrade | Buy | |
2023-10-11 | Seaport Global | Upgrade | Neutral | |
2023-10-08 | Jefferies | Upgrade | Hold | Hold |
2023-10-05 | TD Cowen | Upgrade | Market Perform |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-05-21 | ADKINS RODNEY C. | Director | 30.88K | Stock Award(Grant) |
2024-06-30 | DI SIBIO CARMINE | Director | 4.25K | Stock Award(Grant) |
2024-05-21 | DONAHOE JOHN JOSEPH II | Director | 89.38K | Stock Award(Grant) |
2024-05-21 | DORMAN DAVID WYATT | Director | 70.83K | Stock Award(Grant) |
2024-08-29 | KELLER FRANK | Officer | 26.75K | Conversion of Exercise of derivative security |
2024-05-21 | MCGOVERN GAIL J | Director | 32.18K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 92.34M | 6.16B | 8.41% |
2023-06-29 | Blackrock Inc. | 75.10M | 5.01B | 6.84% |
2023-06-29 | State Street Corporation | 45.85M | 3.06B | 4.18% |
2023-06-29 | Comprehensive Financial Management, LLC | 29.66M | 1.98B | 2.70% |
2023-06-29 | Polen Capital Management, LLC | 22.16M | 1.48B | 2.02% |
2023-06-29 | Geode Capital Management, LLC | 21.12M | 1.41B | 1.92% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 34.80M | 2.32B | 3.17% |
2023-06-29 | Vanguard 500 Index Fund | 26.56M | 1.77B | 2.42% |
2023-08-30 | Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF | 18.91M | 1.18B | 1.72% |
2023-05-30 | Fidelity 500 Index Fund | 12.66M | 784.80M | 1.15% |
2023-08-30 | SPDR S&P 500 ETF Trust | 12.29M | 768.43M | 1.12% |
2023-08-30 | iShares Core S&P 500 ETF | 10.44M | 652.32M | 0.95% |
-
-
-
$PTC Therapeutics(PTCT.US)$ Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics' Royalty on Evrysdi -- Royalty Pharma purchases a portion of royalties on Roche's Evrysdi for
$1.0 billion upfront
-- PTC Therapeutics has option to sell rest of royalty for up to $500
million; Royalty Pharma has option to buy half of rest of royalty for up
to $250 million
-- Transaction expected to enhance long-term Adjusted Cash Receipts growth
(non-GAAP)
-- Royalty Pharma to host conference call today, Thursday, October 19 at
9:00am EDT
NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today an agreement with PTC Therapeutics, Inc. to acquire additional royalties on Roche's Evrysdi for $1.0 billion upfront. The agreement includes options for PTC to sell up to all of its retained royalties on Evrysdi for up to $500 million or for Royalty Pharma to acquire half of such retained royalties for up to $250 million at a later date. -
$PTC Therapeutics(PTCT.US)$ Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics' Royalty on Evrysdi -- Royalty Pharma purchases a portion of royalties on Roche's Evrysdi for
$1.0 billion upfront
-- PTC Therapeutics has option to sell rest of royalty for up to $500
million; Royalty Pharma has option to buy half of rest of royalty for up
to $250 million
-- Transaction expected to enhance long-term Adjusted Cash Receipts growth
(non-GAAP)
-- Royalty Pharma to host conference call today, Thursday, October 19 at
9:00am EDT
NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today an agreement with PTC Therapeutics, Inc. to acquire additional royalties on Roche's Evrysdi for $1.0 billion upfront. The agreement includes options for PTC to sell up to all of its retained royalties on Evrysdi for up to $500 million or for Royalty Pharma to acquire half of such retained royalties for up to $250 million at a later date. -
Fundamentals do not mean anything in this market unfortunately
-
-
-
-
I guess the draftKing CEO and board of directors are not gonna get a bonus this year?
-
-
-
-
-
-
-
-
Regardless the dip that occurs, I've been able to boost 10× my portfolio by following Georgia J Imogen via Instagram... She is truely a genius when it comes to understanding the market
-
Paypal (PYPL) Ascends While Market Falls: Some Facts to Note
news.google.com • -
PayPal Is About To Pay Off
seekingalpha.com • -
PayPal Is About To Pay Off (NASDAQ:PYPL)
news.google.com • -
PayPal Stock Rises On Amazon Prime Checkout Partnership
news.google.com • -
Why I'm Not Booking Profits On PayPal Yet
seekingalpha.com • -
Why I’m Not Booking Profits On PayPal Yet (NASDAQ:PYPL)
news.google.com • -
PYPL vs. FFIV: Which Stock Is the Better Value Option?
news.google.com • -
PayPal forms new partnership with Amazon Buy with Prime (NASDAQ:PYPL)
news.google.com • -
Amazon adds PayPal as a payment option to Buy with Prime
techcrunch.com • -
PayPal: I Have Seen Enough To Trust The Turnaround
seekingalpha.com • -
PayPal: I Have Seen Enough To Trust The Turnaround (PYPL)
news.google.com • -
PayPal (NASDAQ:PYPL) Shares Up 1.1%
news.google.com • -
First Week of PYPL January 2027 Options Trading
news.google.com • -
Here's Why PayPal Could Be a No-Brainer Stock to Buy Before 2025
news.google.com • -
How to Take Advantage of moves in (PYPL)
news.google.com • -
PayPal (NASDAQ:PYPL) Shares Down 0%
news.google.com • -
PayPal Holdings, Inc. (NASDAQ:PYPL) Short Interest Update
news.google.com • -
PayPal Holdings, Inc. (PYPL): A Bull Case Theory
news.google.com • -
PayPal Stock: Buy, Sell, or Hold?
news.google.com • -
PayPal Holdings Looks Like A Buy (Technical Analysis)
news.google.com • -
PayPal Stock: Buy, Sell, or Hold?
news.google.com • -
1 Fantastic Growth Stock Down 76% to Buy Hand Over Fist in 2024
news.google.com • -
PayPal: Value Stock With Momentum Tailwind (NASDAQ:PYPL)
news.google.com • -
Paypal (PYPL) Exceeds Market Returns: Some Facts to Consider
news.google.com • -
PayPal Gains 12.9% YTD: Should You Still Purchase the Stock?
news.google.com • -
November 1st Options Now Available For PayPal Holdings (PYPL)
news.google.com • -
Are Investors Undervaluing PayPal (PYPL) Right Now?
news.google.com • -
PayPal Stock Price Is Breaking Out (NASDAQ:PYPL)
news.google.com • -
PayPal: Too Cheap To Miss Out (NASDAQ:PYPL)
news.google.com •